The Food and Drug Administration is reopening the comment period until May 5 on a proposal to ban companies from listing solid or dried sugar cane syrup as “evaporated cane juice.” FDA had in 2009 requested comments on a draft guidance that would have set the name for solid or dried sugar cane syrup as “dried cane syrup” instead of “evaporated cane juice” on food labels, because the latter falsely suggests the sweetener is juice. FDA said it is now asking for more comments on the issue because it hasn’t yet decided what the name on food labels should be.

On Feb. 28 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Feb. 27 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued its weekly Enforcement Report for Feb. 26 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

On Feb. 25 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Feb. 24 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

During the week of Feb. 17-23, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:

On Feb. 18-21 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued its weekly Enforcement Report for Feb. 19 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

The Food and Drug Administration announced several new initiatives during Commissioner Margaret Hamburg’s recent trip to India, in a bid to build capacity and boost food and drug safety in the country. FDA is in the process of expanding its offices in India to include new staff, said an agency spokesman. During the trip, Hamburg also signed an agreement to work more closely with Indian food and drug regulators.